SCHEMBL30700987

SCHEMBL30700987

COC(=O)c1cc(Br)nc(Cl)c1CBr

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ABL1 P00519 1/20 0.36
NR4A2 P43354 1/20 0.35
NQO2 P16083 6/20 0.35
RXFP1 Q9HBX9 1/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SERPINH1 P50454 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
PLA2G2A P14555 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19778605 0.86 KDM4E (0.49) L3MBTL1KDM4EALDH1A1SMN1; SMN2ABL1
SCHEMBL31267853 0.80 L3MBTL1 (0.41) L3MBTL1KDM4EALDH1A1SMN1; SMN2ABL1
SCHEMBL26040458 0.78 NQO2 (0.46) L3MBTL1KDM4EALDH1A1ABL1NQO2
SCHEMBL23090012 0.75 HPGD (0.41) ALDH1A1SMN1; SMN2ABL1NR4A2GAA
SCHEMBL31160530 0.75 HPGD (0.41) ALDH1A1SMN1; SMN2ABL1NR4A2GAA
SCHEMBL31636694 0.75 ABL1 (0.41) ALDH1A1SMN1; SMN2ABL1NR4A2GAA
SCHEMBL23066024 0.75 ABL1 (0.41) ALDH1A1SMN1; SMN2ABL1NR4A2GAA
SCHEMBL15351124 0.74 ATR (0.50) L3MBTL1KDM4EALDH1A1SMN1; SMN2ABL1
SCHEMBL29593855 0.74 ATR (0.50) L3MBTL1KDM4EALDH1A1SMN1; SMN2ABL1
SCHEMBL22717309 0.72 SMN1; SMN2 (0.45) L3MBTL1KDM4EALDH1A1SMN1; SMN2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724441-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF Revir Therapeutics, Inc. (US) 2026-04-15 EP disclosed
WO-2024251212-A1 ISOINDOLINONE AND DIHYDROPYRROLOPRIDINONE COMPOUNDS AND USES THEREOF REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
WO-2024251211-A1 COMPOSITIONS, METHODS, AND SYSTEMS FOR MODULATING SPLICING OF MSH3 REVIR THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
CN-117295737-A HPK1 antagonists and uses thereof 林伯士萨顿公司 2023-12-26 CN disclosed